Purchase Order 75N92020P00252

Award Date 9/3/20
Potential Completion Date 9/4/20
Potential Value $23K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This federal contract, awarded by the National Center for Advancing Translational Sciences, a civilian agency, to A1 Biochem Labs LLC, provides for the non-GMP scale up synthesis of a specific chemical compound. The contract is a firm fixed price purchase order with a ceiling value of $24,852.00 and a completion date of October 17, 2024. The contract does not have a set-aside designation. No information is provided about any subcontractors involved in this effort.</p>
The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $14,562 firm fixed-price purchase order to A1 Biochem Labs LLC, a small business, to provide the specialized chemical compound 1,3-dimesityl-4,5-bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)-4,5-dihydro-1H-imidazol-3-ium chloride. This purchase order supports research related to the agency's SABRE project and has a completion date of April 2, 2025. The contract was not...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to A1 Biochem Labs LLC, a small business, for the purchase of 34 intermediate chemical compounds in 5g quantities with purity greater than 95%. The total potential value of the award is $112,350.00. This requirement was set aside for total small business participation and is part of the agency's Coronavirus COVID-19...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A &amp; A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A &amp; A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
This federal contract award is for the provision of a biospecimen technician/scientific researcher to support the ongoing clinical and research operations of the National Heart, Lung and Blood Institute (NHLBI). The contract, valued at $102,083.20, is a firm fixed-price delivery order issued under the Multiple Award Schedule (MAS) contract vehicle. The prime contractor is Astrix Technology LLC, a for-profit limited liability company based in Red Bank, New Jersey, that specializes in providing...
This federal contract award, valued at $21,119.70, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to Government Scientific Source Inc., a for-profit organization that specializes in providing laboratory products and equipment to federal agencies. The purpose of this contract is to supply reagents for sequencing to support ongoing clinical research at NHLBI to understand rare and...
This federal contract award, valued at $76,361.60, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The award is a Delivery Order placed under the Multiple Award Schedule (MAS) contract vehicle. The contract was awarded to Government Scientific Source Inc., a for-profit small business organization, to provide a single-cell multiome reagent bundle, single-cell 3' kit V3.1, Chip G kit, Chip J kit, single...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the Department of Health and Human Services (HHS), to Global Life Sciences Solutions USA LLC. The $517,728.16 firm fixed-price purchase order is for the delivery of scientific equipment, biological materials, and associated services to support the agency's biomedical research programs. This award is part of a larger $1.176 billion cooperative agreement with Global Life Sciences...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services, has awarded a firm fixed-price contract to Medical Science &amp; Computing, LLC, a small business, to provide a chemist in support of synthetic chemistry projects and composition production. The contract, which utilizes the Multiple Award Schedule (MAS) contract vehicle, has a period of performance from May 22, 2024 to November 21,...

This federal contract award, valued at $22,952.00, was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to A1 Biochem Labs LLC, a for-profit limited liability company. The contract involves the synthesis of specialized chemical compounds for scientific research purposes. The original solicitation was set aside for total small business participation. A1 Biochem Labs LLC is a specialized chemical research and synthesis laboratory that has secured multiple federal contracts from NHLBI and the National Center for Advancing Translational Sciences, primarily for producing complex organic molecules and intermediate compounds with high purity requirements. This award is one of several firm fixed-price contracts the company has received, demonstrating its expertise in precise chemical synthesis to support scientific research, including efforts related to the COVID-19 response.

Generated 3/14/25, 9:48 AM